Journals / Avrupa Bilim ve Teknoloji Dergisi / 2020 / Cilt: 0 - Sayı: 20

A Comparison of Volumetric Modulated Arc Therapy and Conventional Intensity-Modulated Radiotherapy for High Grade Glial Tumors

Yüksek Dereceli Glial Tümörlerin Radyoterapisinde VMAT Tekniğiİle IMRT Tekniğinin Karşılaştırılması

Pages
404–408
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It may be preferred in plans made with the VMAT technique due to less monitor units (MU) and shortertreatment time.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of radiotherapy is to protect critical organs sensitive to radiation and surrounding healthy tissues as much as possible, whilegiving the most appropriate dose on the specified target volume.
📊
Key Findings & Data:The aim of this study is to provide the best plans of 10 brain tumorpatients, whose computed tomography (CT) image was taken, using the best plans created using the VMAT technique in the Eclipsetreatment planning system and the best plans created using the seven-field IMRT technique to compare doses in terms of target volume,duration of treatment and monitor unit (MU) values.
💡
Conclusion & Impact:It may be preferred in plans made with the VMAT technique due to less monitor units (MU) and shortertreatment time.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The aim of radiotherapy is to protect critical organs sensitive to radiation and surrounding healthy tissues as much as possible, whilegiving the most appropriate dose on the specified target volume. The aim of this study is to provide the best plans of 10 brain tumorpatients, whose computed tomography (CT) image was taken, using the best plans created using the VMAT technique in the Eclipsetreatment planning system and the best plans created using the seven-field IMRT technique to compare doses in terms of target volume,duration of treatment and monitor unit (MU) values. The study is a retrospective study and patients were not treated with the plans andtechniques used in the studies. Plans have been made so that 100% of the dose defined for the target volume will take at least 95% ofthe target volume. Using the Radiation Therapy Oncology Group (RTOG) protocol, the results obtained with the minitab program werestatistically evaluated using the t-test for the matched data. PTV coverage, conformity and homogeneity index were equivalent forVMAT and IMRT plans. VMAT plans compared to IMRT, PTV max. 64,835±0,504 (p=0,039), Brain max. 64,378±0,565 (p=0,025),and Eye L. max. 20,39± 12,17 (p=0,046) The difference between the mean doses is statistically significant. Brain mean 26,74±3,42 (p=0,096), Brainstem max. 32,44±18,70 (p=0,178), Eye R. max. 32,90± 16,84 (p=0,076), Optic Nerve L.max. 23,17± 15,45 (p=0,851),Optic Nerve R. max. 22,63± 17,98 (p=0,688), Optic Chiasma max. 25,25± 20,24 (p=0,531) were found lower in VMAT plans but it was not statistically significant. It may be preferred in plans made with the VMAT technique due to less monitor units (MU) and shortertreatment time.

Özet

Radyoterapide amaç, belirlenen hedef hacim üzerine en uygun dozu verirken, radyasyona hassas kritik organları ve civarındaki sağlıklıdokuları mümkün olduğunca korumaktır. Bu çalışmanın amacı, Bilgisayarlı tomografi (BT) görüntüsü alınmış 10 beyin tümörü tanılıhastanın, Eclipse tedavi planlama sisteminde VMAT tekniği kullanılarak oluşturulan en iyi planlarla, yedi alanlı IMRT tekniğikullanılarak oluşturulan en iyi planları kritik organ dozları, hedef hacim, tedavi süreleri ve monitör unit (MU) değerleri açısındankarşılaştırmaktır. Çalışma retrospektif bir çalışma olup, hastalar çalışmalarda geçen plan ve tekniklerle tedavi edilmemiştir. Hedef hacimiçin tanımlanan dozun %100’ü hedef hacmin en az %95’ini alacak şekilde planlamalar yapılmıştır. Elde edilen doz-volüm histogramlarıaracılığıyla çalışılan farklı planların hedef hacim ve kritik organ dozları Radiation Therapy Oncology Group (RTOG) protokolündenfaydalanarak, eşleşmiş veriler için t – testi kullanılarak minitab programı ile alınan sonuçlar istatistiksel olarak değerlendirilmiştir. PTVkapsamı, konformite ve homojenite indeksi VMAT ve IMRT planları için eşdeğerdi. VMAT planları IMRT ile karşılaştırıldığında PTVmax. 64,835±0,504 (p=0,039), Beyin max. 64,378±0,565 (p=0,025), ve Eye L. max. 20,39± 12,17 (p=0,046) için ortalama dozlarıarasında fark istatistiksel olarak anlamlıdır. Beyin ortalama 26,74±3,42 (p=0,096), Beyin Sapı max. 32,44±18,70 (p=0,178), Eye R.max. 32,90± 16,84 (p=0,076), Optik Nerve L. max. 23,17± 15,45 (p=0,851), Optic Nerve R. max. 22,63± 17,98 (p=0,688), OptikKiazma max. 25,25± 20,24 (p=0,531) dozları VMAT planlarında daha düşük bulunmasına karşılık istatistiksel olarak anlamlı değildir. VMAT tekniği ile yapılan planlarda daha az monitor unit (MU) ve daha kısa tedavi süresi olması nedeniyle tercih edilebilinir.

🔖

Cite This Article

KIZILKAYA, H. O., ARSLAN, D., ÇELEN, Y. Y., OKUMUŞ, A. (2022). A Comparison of Volumetric Modulated Arc Therapy and Conventional Intensity-Modulated Radiotherapy for High Grade Glial Tumors. Avrupa Bilim ve Teknoloji Dergisi, Cilt: 0 - Sayı: 20, 404–408. https://ajindex.com/articles/457586

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Noone, AM, Howlader, N, Krapcho, M, Miller, D, Brest, A, Yu, M, Ruhl, J, Tatalovich, Z, Mariotto, A, Lewis, DR, Chen, HS, Feuer, EJ and Cronin, KA (2015). SEER Cancer Statistics Review, 1975-2015.
  2. National Cancer Institute. Louis, DN, Perry, A, Reifenberger, G, Von Deimling, A, FigarellaBranger, D, Cavenee, WK, Ohgaki, H, Wiestler, OD, Kleihues, P and Ellison, DW (2016). The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathologica, 131 (6), 803- 820. Doi: 10.1007/s00401-016-1545-1
  3. Kleihues, P and Cavenee, WK. (2000). Pathology and Genetics of Tumours of the Nervous System. World Health Organization Classification of Tumours. International Agency for Research on Cancer (IARC). IARC Pres, Lyon, 55- 69. Lyman, JT. (1985). Complication probability as assessed from dosevolume histograms. Radiation Resarch Suppl. 8, 13-19. Doi: 10.2307/3583506 Meral, R. (2007). Radyasyonun Bilissel Fonksiyonlara Etkisi. Türk Nörosirürji Dergisi, 17(3), 139-148.
  4. Çetingöz, R. (2015). Radyoterapi Teknikerlerinin Görev ve Sorumlulukları (p. 5-7). Türk Radyasyon Onkolojisi Derneği Temel ve Klinik Radyoterapi. ISBN:978-605-63913-0-9.Gunderson, LL, Tepper, JE. (2008). Clinical Radiation Oncology (5th edition). Elsevier & Saunders, Philadephia. Hardcover ISBN: 9780323672467. Komaki, R, Meyers, CA, Shin, DM, Garden, AS, Byrne, K, Nickens, JA and Cox JD (1995). Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation. International Journal Radiation Oncology Biol. Phys. 33(1), 179-182. DOI: 10.1016/0360-3016(95)00026-U Narayana, A, Yamada J and Berry S (2006). Intensity-modulated radiotherapy in high-grade gliomas: Clinical and dosimetric results. Int. J. Radiat Oncol Biol Phys 64, 892–897 DOI: 10.1016/j.ijrobp.2005.05.067. Thilmann C, Zabel A, Grosser KH, Hoess A, Wannenmacher M and Debus J (2001). Intensity-modulated radiotherapy with an integrated boost to the macroscopic tumor volume in the treatment of high-grade gliomas. International Journal Cancer, 96:341–349. DOI: 10.1002/ijc.1042. Floyd, NS, Woo, SY, Teh, BS, Prado, C, Mai, YW, Trask, T, Gildenberg, PL, Holoye, P, Augspurger, ME, Carpenter, SL, Lu, HH, Chiu, KJ, Grand, WH and Butler, EB (2004). Hypofractionated intensitymodulated radiotherapy for primary glioblastoma multiforme. International Journal Radiation Oncol. Biol. Phys. 58:721–726. DOI: 10.1016/S0360-3016(03)01623-7 Mi